Lexicon Pharmaceuticals (STU:LX31) FCF Margin %: -69.80% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:LX31 Lexicon Pharmaceuticals Inc STU:LX31
44 GF Score
Price €4.10
! 3 Warning Signs
View Full Analysis

What is Lexicon Pharmaceuticals FCF Margin %?

Lexicon Pharmaceuticals STU:LX31 44 FCF Margin % is -69.80% as of Mar. 2026. GuruFocus rates STU:LX31 with a GF Score™ of 44/100. The stock has 3 warning signs investors should review. Among 950 Biotechnology companies, Lexicon Pharmaceuticals ranks better than 53.58% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Lexicon Pharmaceuticals's Free Cash Flow for the three months ended in Mar. 2026 was €-12.74 Mil. Lexicon Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was €18.25 Mil. Therefore, Lexicon Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was -69.80%.

As of today, Lexicon Pharmaceuticals's current FCF Yield % is -3.81%.

The historical rank and industry rank for Lexicon Pharmaceuticals's FCF Margin % or its related term are showing as below:

STU:LX31' s FCF Margin % Range Over the Past 10 Years
Min: -64875.54   Med: -406.89   Max: 35.31
Current: -55

During the past 13 years, the highest FCF Margin % of Lexicon Pharmaceuticals was 35.31%. The lowest was -64875.54%. And the median was -406.89%.

STU:LX31's FCF Margin % is ranked better than
53.58% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs STU:LX31: -55.00

Lexicon Pharmaceuticals FCF Margin % Related Terms

Lexicon Pharmaceuticals FCF Margin % Historical Data

* Premium members only.

The historical data trend for Lexicon Pharmaceuticals's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lexicon Pharmaceuticals FCF Margin % Chart

Lexicon Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -29,579.92 -64,982.44 -13,486.50 -578.53 -136.24

Lexicon Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,470.01 58.87 -168.05 -313.73 -69.80

STU:LX31 vs CGEM, WVE, CRVS: FCF Margin % Comparison

For the Biotechnology subindustry, Lexicon Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lexicon Pharmaceuticals FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lexicon Pharmaceuticals's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Lexicon Pharmaceuticals's FCF Margin % falls into.


STU:LX31
44GF Score
Lexicon Pharmaceuticals Inc STU:LX31
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lexicon Pharmaceuticals FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Lexicon Pharmaceuticals's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-57.945/42.532
=-136.24 %

Lexicon Pharmaceuticals's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-12.741/18.253
=-69.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -69.80% mean?
Lexicon Pharmaceuticals (STU:LX31) has a FCF Margin % of -69.80% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lexicon Pharmaceuticals and its competitors. According to the industry distribution chart, Lexicon Pharmaceuticals ranks #441 out of 950 companies in the Biotechnology industry, placing it in the top 46.4%.
Is Lexicon Pharmaceuticals' FCF Margin % too high?
Lexicon Pharmaceuticals' current FCF Margin % is -69.80%. Based on the distribution chart, Lexicon Pharmaceuticals ranks #441 out of 950 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Lexicon Pharmaceuticals has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Lexicon Pharmaceuticals' FCF Margin % compare to CGEM and WVE?
According to the Biotechnology industry distribution chart, Lexicon Pharmaceuticals ranks #441 out of 950 companies for FCF Margin %. This puts Lexicon Pharmaceuticals in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lexicon Pharmaceuticals and its competitors. Lexicon Pharmaceuticals's current FCF Margin % is -69.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lexicon Pharmaceuticals stock overvalued right now?
Lexicon Pharmaceuticals (STU:LX31) has a current FCF Margin % of -69.80%. The current FCF Margin % is -69.80%. Lexicon Pharmaceuticals' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Lexicon Pharmaceuticals (STU:LX31), the current FCF Margin % is -69.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lexicon Pharmaceuticals Business Description

Other Exchanges LXRX:USA
Address 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
44GF Score

Get the complete analysis for STU:LX31

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.10
Price